Paradigm Biopharmaceuticals Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Paradigm Biopharmaceuticals Ltd with three other
companies in this sector in AUSTRALIA :
Adalta Ltd
(2020
sales of 3.85 million Australian Dollars [US$2.76 million]
),
Pharmaust Limited
(4.12 million Australian Dollars [US$2.96 million]
), and
Acrux Ltd
(3.95 million Australian Dollars [US$2.83 million]
of which 22%
was Lenezetto).
Sales Analysis.
Paradigm Biopharmaceuticals Ltd reported sales of A$4.70 million (US$3.37 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 44.7%
versus 2019, when the company's sales were A$3.25 million.
Sales at Paradigm Biopharmaceuticals Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 63,950%).